title: Kinds of mutations induced by aflatoxin B1 in a shuttle vector replicating in human cells transiently expressing cytochrome P4501A2 cDNA.
abstract: Transient expression of rat liver cytochrome P450lA2 cDNA was combined with the use of a shuttle vector as a mutational target to determine the frequency and types of mutation caused by the conversion of aflatoxin B1 into genotoxic metabolites within human cells. Ad293 cells were first transfected with p91-lA2, a rat liver P450lA2 cDNA expression vector, or with p91-lA2(i) (a control vector that has the P450 cDNA in the inverted orientation) and incubated for 24 h to permit P450lA2 accumulation. Cells were then transfected with the pS189 shuttle-vector plasmid, which carries the Escherichia coli supF gene as a mutational target, and incubated for a further 24 h in the presence of aflatoxin B1 to permit promutagen activation and pS189 replication. In shuttle vectors replicated in p91-lA2-transfected cells, the supF point-mutation frequency increased with increasing concentration of aflatoxin B1. This frequency was nine to 23 times greater than the background point-mutation frequency obtained with aflatoxin B1-treated control (p91-lA2(i)-transfected) cells. The large majority of the aflatoxin B1-induced supF point mutations were base substitutions, mostly G:C----T:A transversions. This mutagenesis system permits the molecular analysis of mutations induced by specific P450/promutagen pairs in a shuttle vector replicating in human cells and will permit the investigation of host cell mechanisms involved in the generation of these mutations.
authors.affiliation: Centre de recherche en cancérologie, Université Laval, L'Hôtel-Dieu de Québec, Canada.
authors.forename: Y
authors.initials: Y
authors.lastname: Trottier
authors.forename: W I
authors.initials: WI
authors.lastname: Waithe
authors.forename: A
authors.initials: A
authors.lastname: Anderson
mesh_terms: D000348:Aflatoxins / Q000494:pharmacology*; D001426:Bacterial Proteins / Q000235:genetics; D001483:Base Sequence; D002478:Cells, Cultured; D019388:Cytochrome P-450 CYP1A2; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics*; D004247:DNA / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D005822:Genetic Vectors; D006801:Humans; D008969:Molecular Sequence Data; D016296:Mutagenesis; D009154:Mutation; D010088:Oxidoreductases / Q000235:genetics*; D010957:Plasmids; D014162:Transfection
chemical_list: D000348:Aflatoxins; D001426:Bacterial Proteins; C029753:aflatoxin B2; D004247:DNA; D003577:Cytochrome P-450 Enzyme System; D010088:Oxidoreductases; D019388:Cytochrome P-450 CYP1A2